HFG Advisors, Inc. has released its latest holdings report, revealing a total investment value of approximately $157.7 million as of September 30, 2026. This filing is significant as it provides insights into the firm's investment strategies and positions within various sectors, particularly in technology and healthcare.
HFG Advisors, Inc., based in Cincinnati, Ohio, operates under the SEC filing category of other. The firm is registered with the Central Index Key (CIK) number 0001911087 and has been active in reporting its holdings through various forms, including the most recent filing dated November 12, 2026. The firm’s fiscal year ends on December 31.
The latest filing, accession number 0001951757-26-001885, indicates that HFG Advisors holds a diverse portfolio with significant investments in well-known companies. The report lists 120 total entries, showcasing a range of investments across multiple sectors.
Among the notable holdings are major corporations such as Apple Inc., Amazon.com Inc., and Alphabet Inc. The firm has exercised sole investment discretion over these assets, indicating a focused approach to managing its portfolio. For example, HFG Advisors has invested approximately $1.74 million in Apple and $485,592 in Amazon, demonstrating its commitment to leading technology firms.
The filing also highlights investments in healthcare companies, including AbbVie Inc. and Amgen Inc. HFG Advisors has allocated $777,967 to AbbVie and $211,598 to Amgen, reflecting its strategy to capitalize on growth opportunities within the healthcare sector.
This update may have implications for other investment firms as they assess their own strategies in light of HFG Advisors' portfolio choices. The competitive landscape in the investment advisory sector is continually evolving, and firms must adapt to changing market dynamics to maintain their positions.
Looking ahead, HFG Advisors may continue to adjust its holdings based on market conditions and investment opportunities. However, the filing does not specify any upcoming actions or changes beyond the current report.
Read Next
Alpha Tau Medical Reports Positive Interim Results from REGAIN Trial
TOYO Co., Ltd Reports Q3 2026 Results in Latest Filing
NN Inc. to Present at Craig-Hallum Alpha Select Conference
Fresco Gutierrez Diego sells shares of StoneCo Ltd.
Ciena Corp appoints new Chief Product Officer amid changes
Shell plc's Dick Boer Nominated for Philips Supervisory Board










